Fintepla

UCB takes on Jazz in severe epilepsy with new Fintepla approval
Pharmaforum
Mon, 03/28/22 - 10:06 am
UCB Pharma
FDA
Fintepla
Lennox-Gastaut Syndrome
Jazz Pharma
Epidiolex
UCB to buy Zogenix for nearly $2B in 'first step' for M&A in 2022
BioPharma Dive
Wed, 01/19/22 - 11:12 am
UCB Pharma
Zogenix
Fintepla
Dravet syndrome
FDA pushes back decision on Zogenix epilepsy drug
BioPharma Dive
Thu, 02/27/20 - 11:41 pm
Zogenix
epilepsy
Fintepla
FDA
Dravet syndrome
Go or no go? Ozanimod and Fintepla await FDA verdicts
EP Vantage
Wed, 02/26/20 - 10:26 am
Bristol-Myers Squibb
ozaminod
MS
multiple sclerosis
Zogenix
Fintepla
FDA
Zogenix's Positive Clinical Trial Wasn't Positive Enough
Motley Fool
Sun, 02/9/20 - 04:08 pm
Zogenix
epilepsy
Lennox-Gastaut Syndrome
clinical trials
Fintepla
GW Pharma
Epidiolex
Zogenix hands GW a win
EP Vantage
Fri, 02/7/20 - 10:32 am
Lennox-Gastaut Syndrome
clinical trials
Fintepla
Zogenix
GW Pharma
Upcoming events – Genmab's route to market, and late-stage data for Zogenix
EP Vantage
Fri, 01/24/20 - 10:50 am
Genmab
tisotumab vedotin
cervical cancer
Zogenix
Fintepla
Lennox-Gastaut Syndrome
New Data Could Boost Potential Approval of Zogenix's Epilepsy Drug
BioSpace
Fri, 10/25/19 - 10:42 pm
Zogenix
Fintepla
Dravet syndrome
epilepsy
Why Shares of Drugmaker Zogenix Dropped 11.4% in August
Motley Fool
Fri, 09/6/19 - 08:36 pm
Zogenix
Fintepla
Dravet syndrome
Zogenix Prepares for Second Shot at Seizure Drug Submission
BioSpace
Tue, 07/30/19 - 04:23 pm
Zogenix
anti-seizure
FDA
Fintepla
Zogenix plans quick return to the FDA with their spurned application on Dravet syndrome drug — shares spike
Endpoints
Thu, 06/27/19 - 11:42 am
Zogenix
FDA
Dravet syndrome
Fintepla